Effects of fingolimod treatments on alanine transaminase and aspartate transaminase levels in patients with multiple sclerosis

Introduction: Multiple Sclerosis (MS) is a chronic neurological disorder with no known cause or cure. Fingolimod (FTY720) is an oral medication recently approved for the treatment of MS as well as other diseases with autoimmune aspects. However, the drug is not without side effects. The severity and...

全面介紹

Na minha lista:
書目詳細資料
發表在:Int J Physiol Pathophysiol Pharmacol
Main Authors: Joni, Saeid Sadeghi, Cheshmavar, Masoumeh, Shoureshi, Pouria, Zamani, Zohreh, Taoosi, Niusha, Akbari, Morteza, Afzali, Mahdieh
格式: Artigo
語言:Inglês
出版: e-Century Publishing Corporation 2020
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7364390/
https://ncbi.nlm.nih.gov/pubmed/32714497
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍